A head ‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: hypoglycaemia remains the weak spot
This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 28, 2018 Category: Endocrinology Authors: Othmar Moser, Marlene Pandis, Felix Aberer, Harald Kojzar, Daniel Hochfellner, Hesham Elsayed, Melanie Motschnig, Thomas Augustin, Philipp Kreuzer, Thomas R. Pieber, Harald Sourij, Julia K. Mader Tags: BRIEF REPORT Source Type: research

DREAM5: An open ‐label, randomized, cross‐over study to evaluate the safety and efficacy of day and night closed‐loop control using the MD‐Logic automated insulin delivery system compared to sensor augmented pump therapy in patients with type 1 diabetes at home
ConclusionsThe MD ‐Logic system was safe and associated with better glycemic control over SAP therapy for day and night use. The lack of remote monitoring did not lead to safety signals in adapting basal rates as well as in administration of automated bolus corrections.This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 26, 2018 Category: Endocrinology Authors: Torben Biester, Judith Nir, Kerstin Remus, Alon Farfel, Ido Muller, Sarah Biester, Eran Atlas, Klemen Dovc, Natasa Bratina, Olga Kordonouri, Tadej Battelino, Moshe Philip, Thomas Danne, Revital Nimri Tags: ORIGINAL ARTICLE Source Type: research

Exenatide use and Incidence of Pancreatic and Thyroid Cancer: A Retrospective Cohort Study
This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 25, 2018 Category: Endocrinology Authors: Caihua Liang, Monica L. Bertoia, Yan Ding, C. Robin Clifford, Qing Qiao, Joshua J. Gagne, David D. Dore Tags: ORIGINAL ARTICLE Source Type: research

Identification of autoimmune type 1 diabetes and multiple organ ‐specific autoantibodies in adult‐onset non‐insulin requiring diabetes in China: a population based multicenter national wide survey
ConclusionsA proportion of phenotypic T2D patients in China have adult ‐onset autoimmune diabetes with diabetes‐associated autoantibodies and theymay be at risk of developing other organ ‐specific autoimmune diseases. Therefore, itmay be clinically relevant to consider screening such Chinese populations.This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 24, 2018 Category: Endocrinology Authors: Yufei Xiang, Gan Huang, Yaxi Zhu, Xuan Zuo, Xinyuan Liu, Qiong Feng, Xia Li, Tubao Yang, Juming Lu, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji, Dalong Zhu, Jiapu Ge, Lixiang Lin, Li Chen, Xiaohui Guo, Zhigang Zhao, Qiang Li, Jianpi Tags: ORIGINAL ARTICLE Source Type: research

Reflections on the Sulphonylurea Story. A Drug Class at Risk of Extinction? Or A Drug Class Worth Reviving?
This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 24, 2018 Category: Endocrinology Authors: RLM Cordiner, ER Pearson Tags: REVIEW ARTICLE Source Type: research

Glycaemic Efficacy and Safety of Linagliptin compared to Basal ‐Bolus Insulin Regimen in Patients with Type 2 Diabetes Undergoing Non‐Cardiac Surgery: A Multicenter Randomized Clinical Trial
AimsThe use of incretin ‐based therapy instead of or complementary to insulin therapy is an active area of research in hospitalized patients with type 2 diabetes (T2D). We determined glycaemic efficacy and safety of linagliptin compared to basal‐bolus insulin regimen in hospitalized surgical patients with T2D.Materials and MethodsThis prospective open ‐label multicenter study randomized T2D patients undergoing non‐cardiac surgery with admission blood glucose(BG) 7.8‐22.2 mmol/L treated with diet, oral agents or total insulin dose(TDD) ≤0.5 units/kg/day to linagliptin(n=128) daily or basal‐bolus(n=122) with g...
Source: Diabetes, Obesity and Metabolism - November 20, 2018 Category: Endocrinology Authors: Priyathama Vellanki, Neda Rasouli, David Baldwin, Sara Alexanian, Isabel Anzola, Maria Urrutia, Saumeth Cardona, Limin Peng, Francisco J. Pasquel, Guillermo E. Umpierrez, Linagliptin Inpatient Research Group Tags: ORIGINAL ARTICLE Source Type: research

Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real ‐world studies
ConclusionsThe HAT data on hypoglycaemia incidence were comparable with those from other real ‐world studies and indicate a high incidence of hypoglycaemia among insulin‐treated patients. Differences in rates between studies are mostly explained by differences in patient populations and study methodology. The goal of reducing hypoglycaemia should be a target for continued educational and evidence‐based pharmacological interventions.This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 20, 2018 Category: Endocrinology Authors: Ulrik Pedersen ‐Bjergaard, Saud Alsifri, Ronnie Aronson, Maja Cigrovski Berković, Gagik Galstyan, Helge Gydesen, Jesper Barner Lekdorf, Bernhard Ludvik, Erik Moberg, Ambady Ramachandran, Kamlesh Khunti Tags: ORIGINAL ARTICLE Source Type: research

The Impact of Metformin Use on the Cardiovascular Effects of DPP ‐4 Inhibitors: an Analysis of Medicare Claims Data 2007‐2015
ConclusionsIncidence rate differences in multiple cardiovascular outcomes appeared more favorable when DPP ‐4i initiation occurred in the presence of metformin, suggesting a possible interaction between DPP‐4i and metformin.This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 20, 2018 Category: Endocrinology Authors: Matthew J. Crowley, Mugdha Gokhale, Virginia Pate, Til St ürmer, John B. Buse Tags: ORIGINAL ARTICLE Source Type: research

Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT)
Obesity is a global pandemic with immense health consequences for individuals and societies. Multiple factors, including environmental influences and genetic predispositions, are known to affect the development of obesity. Despite an increasing understanding of the factors driving the obesity epidemic, therapeutic interventions to prevent or reverse obesity are limited in their impact. Manipulation of the human gut microbiome provides a new potential therapeutic approach in the fight against obesity. Specific gut bacteria and their metabolites are known to affect host metabolism and feeding behaviour, and dysbiosis of this...
Source: Diabetes, Obesity and Metabolism - November 20, 2018 Category: Endocrinology Authors: Patrick Lee, Bruce R. Yacyshyn, Mary B. Yacyshyn Tags: REVIEW ARTICLE Source Type: research

Of mice and men: is there a future for metformin in the treatment of hepatic steatosis?
This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 19, 2018 Category: Endocrinology Authors: C.J Green, T Marjot, J.W Tomlinson, L Hodson Tags: REVIEW ARTICLE Source Type: research

Liraglutide pharmacotherapy reduces body weight and improves glycemic control in juvenile obese / hyperglycemic male and female rats
ConclusionThese preclinical data suggest that maternal and early ‐life consumption of HFSD increases caloric intake, body weight gain and hyperglycemia, a collective set of unwanted metabolic effects that appear to be treatable in juveniles with liraglutide pharmacotherapy intervention.This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 19, 2018 Category: Endocrinology Authors: Claudia G. Liberini, Rinzin Lhamo, Misgana Ghidewon, Tyler Ling, Nina Juntereal, Jack Chen, Anh Cao, Lauren M. Stein, Matthew R. Hayes Tags: ORIGINAL ARTICLE Source Type: research

Urinary glucose excretion after dapagliflozin treatment: an exposure –response modeling comparison between Japanese and non‐Japanese patients diagnosed with Type 1 Diabetes Mellitus
ConclusionsThere was no difference in dapagliflozin exposure –response in Japanese and non‐Japanese patients with T1DM once differences in renal function, glycemic control and insulin dose reductions between studies were considered. Therefore, no dose adjustment is recommended in Japanese patients with T1DM.This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 19, 2018 Category: Endocrinology Authors: Victor Sokolov, Tatiana Yakovleva, Shinya Ueda, Joanna Parkinson, David W. Boulton, Robert C. Penland, Weifeng Tang Tags: ORIGINAL ARTICLE Source Type: research

Prevalence of heart failure and diagnostic value of MR ‐proANP in outpatients with type 2 diabetes
Non ‐structured abstractThe prevalence of heart failure (HF) in patients with type 2 diabetes (T2DM) is debatable and no data exist on the diagnostic value of mid ‐regional pro‐atrial natriuretic peptide (MR‐proANP). We aimed to identify the HF prevalence and evaluate the diagnostic value of MR‐proANP in outpatients followed in two specialized diabetes clinics. HF was pre‐defined as HF with reduced (HFrEF) and preserved (HFpEF) ejection fraction. Th e prevalence of HFrEF and HFpEF was 2.4% and 17.5%, respectively. An MR‐proANP
Source: Diabetes, Obesity and Metabolism - November 16, 2018 Category: Endocrinology Authors: Jesper Jensen, Morten Schou, Caroline Kistorp, Jens Faber, Tine W. Hansen, Magnus T. Jensen, Henrik U. Andersen, Peter Rossing, Tina Vilsb øll, Peter G. Jørgensen Tags: BRIEF REPORT Source Type: research

Effect of Canagliflozin Treatment on Hepatic Triglyceride Content and Glucose Metabolism in Patients with Type 2 Diabetes
AIMSCanagliflozin, a sodium glucose co ‐transporter 2 inhibitor, improves glycemic control by increasing urinary glucose excretion, but its impact on intrahepatic triglyceride (IHTG) accumulation and relationship to changes in body weight and glucose metabolism remain unknown.MATERIALS AND METHODSIn this double ‐blind, parallel‐group, placebo‐controlled, 24‐week trial subjects with inadequately controlled type 2 diabetes mellitus (T2DM; HbA1c=7.7±0.7%) from two centers were randomly assigned (1:1) to canagliflozin 300 mg or placebo. We measured IHTG by proton‐magnetic resonance spectroscopy (pri mary out...
Source: Diabetes, Obesity and Metabolism - November 16, 2018 Category: Endocrinology Authors: Kenneth Cusi, Fernando Bril, Diana Barb, David Polidori, Sue Sha, Atalanta Ghosh, Kristin Farrell, Nishanth E. Sunny, Srilaxmi Kalavalapalli, Jeremy Pettus, Theodore P. Ciaraldi, Sunder Mudaliar, Robert R. Henry Tags: ORIGINAL ARTICLE Source Type: research

The effect of glycemic control on cardiovascular disease in individuals with type 2 diabetes with pre ‐existing cardiovascular disease ‐ a systematic review and meta‐analysis
In conclusion, in people with diabetes and pre‐existing CVD, intensive glucose control vs. standard care had a neutral effect on incident CV events.This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 13, 2018 Category: Endocrinology Authors: Yael Barer, Ohad Cohen, Tali Cukierman ‐Yaffe Tags: BRIEF REPORT Source Type: research

Insulin glargine/lixisenatide fixed ‐ratio combination improves glycaemic variability and control without increasing hypoglycaemia
This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 13, 2018 Category: Endocrinology Authors: Ronnie Aronson, Guillermo Umpierrez, William Stager, Boris Kovatchev Tags: BRIEF REPORT Source Type: research

Diabetes, Obesity and Metabolism
, Volume 20, Issue 12, Page 2709-2710, December 2018. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 11, 2018 Category: Endocrinology Tags: ISSUE INFORMATION Source Type: research

GlucoTab ‐guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes
AimsTo investigate efficacy, safety and usability of the GlucoTab system for glycaemic management using insulin glargine U300 in non ‐critically ill hospitalized patients with type 2 diabetes (T2D).Materials and MethodsIn this open, non ‐controlled single‐arm pilot study, glycaemic control at the general ward of a tertiary care hospital was guided by a mobile decision support system (GlucoTab) for basal‐bolus insulin dosing using the novel basal insulin analogue insulin glargine U300 for the first time. Glycaemic control was surveilled with capillary glucose measurements and continuous glucose monitoring (CGM). The...
Source: Diabetes, Obesity and Metabolism - November 11, 2018 Category: Endocrinology Authors: Felix Aberer, Katharina M. Lichtenegger, Edin Smajic, Klaus Donsa, Oliver Malle, Judith Samonigg, Bernhard H öll, Peter Beck, Thomas R. Pieber, Johannes Plank, Julia K. Mader Tags: ORIGINAL ARTICLE Source Type: research

The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes
ObjectiveOur aim was to define the relationships between plasma biomarkers of kidney injury and intrarenal haemodynamic function (glomerular filtration rate [GFR], effective renal plasma flow [ERPF], renal vascular resistance [RVR]) in adults with type 1 diabetes (T1D).MethodsThe study sample comprised patients with longstanding T1D (duration ≥50 years), among whom 44 were diabetic kidney disease (DKD) resistors (eGFR>60  mL/min/1.73 m2 and
Source: Diabetes, Obesity and Metabolism - November 11, 2018 Category: Endocrinology Authors: Petter Bjornstad, Sunita K. Singh, Janet K. Snell ‐Bergeon, Julie A. Lovshin, Yuliya Lytvyn, Leif E. Lovblom, Marian J. Rewers, Genevieve Boulet, Vesta Lai, Josephine Tse, Leslie Cham, Andrej Orszag, Alanna Weisman, Hillary A. Keenan, Mich Tags: ORIGINAL ARTICLE Source Type: research

Reduction in Albuminuria With Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers
This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 9, 2018 Category: Endocrinology Authors: Hiddo J.L. Heerspink, C. David Sj öström, Silvio E. Inzucchi, Melissa K. Hallow, Valerie A. Cain, Peter Rossing, Bergur V. Stefansson, Peter Sartipy Tags: BRIEF REPORT Source Type: research

Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient ‐level pooled analysis of EDITION 1, 2 and 3
This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 9, 2018 Category: Endocrinology Authors: Riccardo C. Bonadonna, Jean ‐François Yale, Claire Brulle‐Wohlhueter, Emmanuelle Boëlle‐Le Corfec, Pratik Choudhary, Timothy S. Bailey Tags: BRIEF REPORT Source Type: research

What the diabetes data in FOURIER trial fail to show
This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 8, 2018 Category: Endocrinology Authors: F.H. van Bruggen, H. J. Luijendijk Tags: LETTER TO THE EDITOR Source Type: research

SGLT2 inhibitor regulates ketone body metabolism via inter ‐organ crosstalk
ConclusionsSGLT2i increased systemic and tissue BHB levels by upregulating ketogenic enzymes and transporters in the liver, kidney, and intestine, suggesting the integrated physiological consequences in ketone body metabolism by SGLT2i administration.This article is protected by copyright. All rights reserved. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 8, 2018 Category: Endocrinology Authors: Jin Hee Kim, Minyoung Lee, Soo Hyun Kim, So Ra Kim, Byung ‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Jin Won Cho, Yong‐ho Lee Tags: ORIGINAL ARTICLE Source Type: research

Effect of switching from pioglitazone to the sodium glucose co ‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus: An open‐label, prospective, randomized, parallel‐group comparison trial
The effects of dapagliflozin (DAP) and pioglitazone (PIO) on body weight and glycaemic control were compared in patients with type 2 diabetes mellitus. Seventy ‐one patients on PIO were either switched to DAP (n = 36) at 5 mg per day or continued on PIO (n = 35). Primary endpoints were superiority of body weight loss and non‐inferiority of HbA1c level after 24 weeks with DAP. Body weight decrease was greater with DAP than with PIO (75.3 ±  14.9 to 71.3 ± 15.1 kg vs. 74.7 ± 13.8 to 75.2 ± 13.9 kg;P 
Source: Diabetes, Obesity and Metabolism - November 8, 2018 Category: Endocrinology Authors: Kyu Yong Cho, Akinobu Nakamura, Kazuno Omori, Takahiro Takase, Aika Miya, Naoki Manda, Yoshio Kurihara, Shin Aoki, Tatsuya Atsumi, Hideaki Miyoshi Tags: BRIEF REPORT Source Type: research

Corrigendum
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 8, 2018 Category: Endocrinology Tags: CORRIGENDUM Source Type: research

Prevalence and progression of diabetic nephropathy in South Asians, White Europeans and Afro ‐Caribbeans with Type 2 diabetes; a systematic review and meta‐analysis
IntroductionDiabetic nephropathy remains the most common cause of renal disease in patients diagnosed with type 2 diabetes.AimsWe conducted a systematic review and meta ‐analysis of published observational evidence to assess the difference in the prevalence and progression of diabetic nephropathy, and the development of end‐stage renal failure in three ethnicities with type 2 diabetes.MethodsRelevant studies were identified in a literature search of MEDLINE, EMBASE, and reference lists of relevant studies to May 2018. We decideda priori that there were no differences in the prevalence and progression of diabetic nephro...
Source: Diabetes, Obesity and Metabolism - November 8, 2018 Category: Endocrinology Authors: Chandni Jadawji, Winston Crasto, Clare Gillies, Debasish Kar, Melanie J Davies, Kamlesh Khunti, Samuel Seidu Tags: ORIGINAL ARTICLE Source Type: research

Achieving LDL ‐C target levels less than 70 mg/dL may provide extra cardiovascular protection in high‐risk patients: exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients With Hypercholesterolemia and Diabetic Retinopathy Study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 5, 2018 Category: Endocrinology Authors: Hiroshi Itoh, Issei Komuro, Masahiro Takeuchi, Takashi Akasaka, Hiroyuki Daida, Yoshiki Egashira, Hideo Fujita, Jitsuo Higaki, Ken ‐ichi Hirata, Shun Ishibashi, Takaaki Isshiki, Sadayoshi Ito, Atsunori Kashiwagi, Satoshi Kato, Kazuo Kitaga Source Type: research

Double ‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 5, 2018 Category: Endocrinology Authors: Ronan Roussel, Santiago Dur án García, Yilong Zhang, Suneri Shah, Carolyn Darmiento, R. Ravi Shankar, Gregory T. Golm, Raymond L.H. Lam, Edward A. O'Neill, Ira Gantz, Keith D. Kaufman, Samuel S. Engel Source Type: research

CANadian CAnagliflozin Registry: Effectiveness and Safety of Canagliflozin in the treatment of Type 2 diabetes mellitus in Canadian Clinical Practice
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 5, 2018 Category: Endocrinology Authors: Vincent Woo, Alan Bell, Maureen Clement, Luis Noronha, Michael A. Tsoukas, Fernando Camacho, Shana Traina, Natasha Georgijev, Matthew D. Culham, Jennifer B. Rose, Wally Rapattoni, Harpreet S. Bajaj Source Type: research

Follistatins in glucose regulation of healthy and obese subjects
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 5, 2018 Category: Endocrinology Authors: Nikolaos Perakakis, Alexander Kokkinos, Natia Peradze, Nicholas Tentolouris, Wael Ghaly, Dimitrios Tsilingiris, Andreas Alexandrou, Christos S. Mantzoros Source Type: research

Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in people with type 2 diabetes: Findings of a randomized cross ‐over trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - November 5, 2018 Category: Endocrinology Authors: Shaun A. Mason, Bodil Rasmussen, Luc J.C. van Loon, Jo Salmon, Glenn D. Wadley Source Type: research

Hypoglycaemia and gastric emptying
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 31, 2018 Category: Endocrinology Authors: Chinmay S Marathe, Jessica A Marathe, Christopher K Rayner, Palash Kar, Karen L Jones, Michael Horowitz Source Type: research

Personalized risk ‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 31, 2018 Category: Endocrinology Authors: Marta Garc ía‐Fiñana, David M. Hughes, Christopher P. Cheyne, Deborah M. Broadbent, Amu Wang, Arnošt Komárek, Irene M. Stratton, Mehrdad Mobayen‐Rahni, Ayesh Alshukri, Jiten P. Vora, Simon P. Harding Source Type: research

Effects of acute insulin ‐induced hypoglycaemia on endothelial microparticles in adults with and without type 2 diabetes
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 31, 2018 Category: Endocrinology Authors: Ahmed Al ‐Qaissi, Maria Papageorgiou, Harshal Deshmukh, Leigh A. Madden, Alan Rigby, Eric S. Kilpatrick, Stephen L. Atkin, Thozhukat Sathyapalan Source Type: research

Effectiveness of high ‐intensity interval training combined with resistance training versus continuous moderate‐intensity training combined with resistance training in patients with type 2 diabetes: A one‐year randomized controlled trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 29, 2018 Category: Endocrinology Authors: Jo ão P. Magalhães, Pedro B. Júdice, Rogério Ribeiro, Rita Andrade, João Raposo, Hélder Dores, Manuel Bicho, Luís B. Sardinha Source Type: research

Effect of selenium supplementation on changes in HbA1c: Results from a multiple ‐dose, randomized controlled trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 29, 2018 Category: Endocrinology Authors: Saverio Stranges, Margaret P. Rayman, Kristian H. Winther, Eliseo Guallar, S øren Cold, Roberto Pastor‐Barriuso Source Type: research

Temporal changes in the incidence and predictors of severe hypoglycaemia in type 2 diabetes: The Fremantle Diabetes Study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 29, 2018 Category: Endocrinology Authors: Timothy M. E. Davis, David G. Bruce, Judith Finn, Bradley H. Curtis, Helen Barraclough, Wendy A. Davis Source Type: research

Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon ‐like peptide‐1, and gastric emptying after oral glucose, in type 2 diabetes
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 29, 2018 Category: Endocrinology Authors: Malcolm J Borg, Michelle Bound, Jacqueline Grivell, Zilin Sun, Karen L Jones, Michael Horowitz, Christopher K Rayner, Tongzhi Wu Source Type: research

Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double ‐blind, non‐inferiority trial
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 26, 2018 Category: Endocrinology Authors: Yonghyun Kim, Eun Seok Kang, Hak Chul Jang, Dong Jun Kim, Taekeun Oh, Eun Sook Kim, Nan ‐Hee Kim, Kyung Mook Choi, Sung‐Rae Kim, JiYoung You, Se‐Jin Kim, Moon‐Kyu Lee Source Type: research

Day ‐to‐day Fasting Self‐monitored Blood Glucose Variability is Associated with Risk of Hypoglycaemia in Insulin‐Treated Patients with Type 1 and Type 2 Diabetes: A Post Hoc Analysis of the SWITCH Trials
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 26, 2018 Category: Endocrinology Authors: J. Hans DeVries, Timothy S. Bailey, Anuj Bhargava, Gregg Gerety, Janusz Gumprecht, Simon Heller, Wendy Lane, Carol H. Wysham, Bernard Zinman, Britta A. Bak, Elise Hachmann ‐Nielsen, Athena Philis‐Tsimikas Source Type: research

Evaluation of the Long ‐Term Cost‐Effectiveness of Once‐Weekly semaglutide versus dulaglutide for the treatment of type 2 diabetes mellitus in the UK
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 26, 2018 Category: Endocrinology Authors: Adie Viljoen, Christina Stentoft Hoxer, Pierre Johansen, Samuel Malkin, Barnaby Hunt, Stephen C Bain Source Type: research

Corrigendum
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 25, 2018 Category: Endocrinology Source Type: research

Exenatide corrects postprandial hyperglycaemia in young people with cystic fibrosis and impaired glucose tolerance: A randomized crossover trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 25, 2018 Category: Endocrinology Authors: Myfanwy C. Geyer, Thomas Sullivan, Andrew Tai, Judith M. Morton, Suzanne Edwards, A. James Martin, Shiree J. Perano, Lucia Gagliardi, Christopher K. Rayner, Michael Horowitz, Jennifer J. Couper Source Type: research

Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 23, 2018 Category: Endocrinology Authors: Ulrike H övelmann, Minna Brændholt Olsen, Ulrik Mouritzen, Daniela Lamers, Birgit Kronshage, Tim Heise Source Type: research

Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double ‐blind, placebo‐controlled trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 23, 2018 Category: Endocrinology Authors: Aris Liakos, Vaia Lambadiari, Alexandra Bargiota, Konstantinos Kitsios, Iakovos Avramidis, Kalliopi Kotsa, Spyridon Gerou, Panagiota Boura, Nikolaos Tentolouris, George Dimitriadis, Apostolos Tsapas Source Type: research

Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized 13C magnetic resonance spectroscopy study
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 18, 2018 Category: Endocrinology Authors: Desiree Abdurrachim, Xing Qi Teo, Chern Chiuh Woo, Wei Xin Chan, Janise Lalic, Carolyn S. P. Lam, Philip Teck Hock Lee Source Type: research

Gut microbiota and obesity: An opportunity to alter obesity through Fecal Microbiota Transplant (FMT)
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 17, 2018 Category: Endocrinology Authors: Patrick Lee, Bruce R. Yacyshyn, Mary Beth Yacyshyn Source Type: research

FGF21 decreases food intake and body weight in obese G öttingen minipigs
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 17, 2018 Category: Endocrinology Authors: Berit Christoffersen, Ellen M. Straarup, Kirsten Lykkegaard, Johannes Josef Fels, Kristian Sass ‐Ørum, Xujia Zhang, Kirsten Raun, Birgitte Andersen Source Type: research

GlucoTab guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalised patients with type 2 diabetes
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 17, 2018 Category: Endocrinology Authors: Felix Aberer, Katharina M. Lichtenegger, Edin Smajic, Klaus Donsa, Oliver Malle, Judith Samonigg, Bernhard H öll, Peter Beck, Thomas R. Pieber, Johannes Plank, Julia K. Mader Source Type: research

Acute renal outcomes with sodium ‐glucose co‐transporter‐2 inhibitors: Real‐world data analysis
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - October 16, 2018 Category: Endocrinology Authors: Avivit Cahn, Cheli Melzer ‐Cohen, Rena Pollack, Gabriel Chodick, Varda Shalev Source Type: research